More Europeans are flying to Canada than ever before, aviation data shows
It's up 40% over the past decade, with Air Canada adding over 100 flights since last year.
It comes after both sides showed less interest in traveling to the US since Trump's election.
According to data from the aviation analytics firm Cirium, a record-breaking 4,276 flights are scheduled between Canada and Europe this month.
That's up 5% since the same period last year, 14% since before the pandemic, and more than 40% over the past decade.
The rise has been backed by flag carrier Air Canada, which added an extra 112 flights, or 34,500 seats, this month.
It opened five new transatlantic routes, including Edinburgh, Scotland, and Naples, Italy, to Montreal.
Flights between the US and Europe have been growing too, but not as quickly.
Cirium data shows a rise of 4% between August 2024 and August 2025, and one-third between August 2015 and August 2025.
Airlines have raised concerns that fewer people are interested in visiting the US since Donald Trump began his second presidency in January.
For July and August, airlines cut capacity by 3.5% on routes between the US and Canada, OAG reported in March.
"This sharp drop suggests that travelers are holding off on making reservations, likely due to ongoing uncertainty surrounding the broader trade dispute," said John Grant, the travel data firm's chief analyst.
While political tensions also saw bookings drop from Europe, price cuts helped encourage a rebound in May, Nicholas Smith, holidays digital director at Thomas Cook and eSky Group, told Business Insider's Thibault Spirlet in June.
Nonetheless, it may be that more Europeans are now choosing Canada instead of the US for a transatlantic vacation.
In April, the CEO of hotel giant Accor told Bloomberg that forward bookings for Europeans visiting the US this summer have fallen by a quarter. He added that they were instead looking at destinations like Canada and South America.
And while many Americans are still enjoying their " Euro Summers," the post-pandemic explosion of such trips may start to wane.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Nio Inc. (NIO) umbles 8% as Slow July Deliveries Growth Disappoint
We recently published . NIO Inc. (NYSE:NIO) is one of the companies that stood stronger last week. Nio Inc. dropped its share prices by 8.18 percent on Monday to close at $4.6 apiece as investors soured on the slower growth in vehicle deliveries last month. In a statement on Friday, NIO Inc. (NYSE:NIO) said it delivered 21,017 vehicles last month, higher by 2.5 percent than the 20,498 in the same period last year, but was notably slower than the double-digit year-on-year growth in the past three months. Year-on-year, June deliveries were higher by 17 percent; May was up by 13 percent; while April increased by 53 percent. Copyright: zenstock / 123RF Stock Photo According to NIO Inc. (NYSE:NIO), July's deliveries consisted of 12,675 vehicles from NIO's premium smart electric vehicle brand NIO; 5,976 vehicles from the family-oriented smart electric vehicle brand ONVO; and 2,366 vehicles from the small smart high-end electric car brand Firefly. To date, the company has already delivered a cumulative total of 806,731 vehicles, of which the NIO brand accounted for 737,923, followed by the ONVO brand with 58,599, and Firefly with 10,209. While we acknowledge the potential of NIO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio
Yahoo
2 minutes ago
- Yahoo
TG Therapeutics (TGTX) Slashes 18% on Lower 2025 Sales Guidance
We recently published . TG Therapeutics, Inc. (NASDAQ:TGTX) is one of the companies that stood stronger last week. TG Therapeutics fell for a third day on Monday, shedding 18 percent to close at $28.72 apiece as investors soured on a lower-than-expected full-year sales guidance. In a statement, TG Therapeutics, Inc. (NASDAQ:TGTX) raised its revenue outlook for Briumvi to a range of $570 million to $575 million from the $560 million previously, but was still lower than the $596 million as expected by analysts. The company also upped its total global revenue target to $585 million for the full year 2025 from its previous outlook of $575 million year-on-year. In the second quarter of the year, TG Therapeutics, Inc. (NASDAQ:TGTX) posted a net income 310-percent expansion in net income to $28.19 million from $6.88 million in the same period last year. Total revenues were also higher by 93 percent to $141 million from $73 million in the same comparable period. The company also swung to a net profit of $33 million from a $3.8-million net loss in the same period last year. While we acknowledge the potential of TGTX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 minutes ago
- Yahoo
LyondellBasell (LYB) Drops on 6th Day as Earnings Disappoint
We recently published . LyondellBasell Industries N.V. (NYSE:LYB) is one of the companies that stood stronger last week. LyondellBasell dropped its share prices for a sixth straight day on Monday, shedding 4.72 percent to close at $50.9 apiece as investors continued to unload positions following a disappointing earnings performance in the first half of the year. In a statement, LyondellBasell Industries N.V. (NYSE:LYB) said net income in the second quarter of the year declined by 87 percent to $115 million from $924 million in the same period last year, dragged down by asset write-downs, transaction costs, cash improvement plans, and discontinued operations. Sales and operating revenues decreased by 11 percent to $7.66 billion from $8.68 billion. Copyright: art9858 / 123RF Stock Photo Net income for the first half also dwindled by 79 percent to $292 million from $1.397 billion, while sales and operating revenues declined by 9.9 percent to $15.3 billion from $16.98 billion year-on-year. Meanwhile, LyondellBasell Industries N.V. (NYSE:LYB) announced the distribution of $1.37 per share to shareholders as of August 25, payable on September 2, 2025. While we acknowledge the potential of LYB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data